logo

Beigene (BGNE)



Trade BGNE now with
  Date
  Headline
8/18/2021 4:19:16 AM BeiGene : Swissmedic Accepts Marketing Application For BRUKINSA In Waldenström's Macroglobulinaemia
9/21/2020 7:06:01 AM Leap Therapeutics And BeiGene Says First Patient Dosed In DisTinGuish Study
7/27/2020 9:21:44 AM BeiGene Says Priority Review Granted To NDA Of Pamiparib In Ovarian Cancer In China
7/17/2020 9:03:02 AM BeiGene Reports Acceptance Of NDA Of Pamiparib In Ovarian Cancer In China
7/1/2020 7:09:49 AM BeiGene Appoints Angus Grant As Chief Business Executive
6/19/2020 12:34:10 AM BeiGene Announces Acceptance Of SNDA For Tislelizumab In Combination With Chemotherapy In China
6/18/2020 7:33:51 AM BeiGene Reports EMA Acceptance Of Its Marketing Authorization Application For BRUKINSA
6/3/2020 7:18:29 AM BeiGene Says BTK Inhibitor BRUKINSA Has Received Approval From NMPA In Two Indications
5/29/2020 8:28:46 AM BeiGene Presents Phase 3 Data On Tislelizumab Combined With Chemotherapy
4/20/2020 4:16:46 PM BeiGene Says China Accepted SNDA Of Anti-PD-1 Antibody Tislelizumab Plus Chemotherapy For First-line Treatment Of NSCLC
3/25/2020 9:05:57 AM BeiGene: NMPA Suspended Importation, Sales And Use Of ABRAXANE In China